LDH-A,a potential molecular target for cancer therapy and development of specific inhibitors from spatholobus suberectus
Objective Although clinical outcomes of some cancer have been greatly improved by advancements made in surgery,chemo or radiotherapy and development of novel strategies such as molecular targeted therapy,Traditional Chinese Medicine (TCM) is particularly appreciated for cancer therapy in China based on its 5 000-year-old history,however,due to lack of quality assurance,laboratory evidences TCM always encounters much skepticism and pessimism by the West.
Wang ZY Shen JG Chen JP
School of Chinese medicine,the University of Hong Kong
国内会议
三亚
英文
165-165
2012-11-16(万方平台首次上网日期,不代表论文的发表时间)